Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis

Clinical Rheumatology
N InancM Inanc

Abstract

Our aim is to assess the prevalence and associated clinical features of anti-CCP (cyclic citrullinated peptide) antibodies for RF (rheumatoid factor)-positive and RF-negative rheumatoid arthritis (RA) and psoriatic arthritis (PsA). In a prospective, cross-sectional, multi-centre study, we determined the titres of anti-CCP antibodies in 208 RA patients (129 RF-positive, 79 RF-negative), 56 PsA patients and 39 healthy controls (HC). Clinical parameters including disease activity (disease activity score 28-DAS28), physical disability (health assessment questionnaire-HAQ), functional capacity (functional class) and radiological erosions were investigated in patients with RA. In PsA patients, clinical and radiological features were determined. Anti-CCP2 antibodies were measured using a second-generation anti-CCP enzyme-linked immunosorbent assay (Euro-Diagnostica, Netherlands). One-hundred four of 129 RF-positive RA (81%), 16 of 79 RF-negative RA (20%), seven of 56 PsA patients (12.5%) and none of the HC had anti-CCP antibodies. RA patients with anti-CCP antibodies had significantly higher disease activity, greater loss of function and more frequent erosive disease than anti-CCP antibody-negative group. In subgroup analysis, anti-CC...Continue Reading

References

Jan 22, 2000·Arthritis and Rheumatism·G A SchellekensW J van Venrooij
Nov 1, 2000·Arthritis Research·R Goldbach-ManskyH S El-Gabalawy
Mar 7, 2002·Arthritis Research·Martinus A M van BoekelWalther J van Venrooij
Jul 12, 2002·Arthritis Research·Günter Steiner, Josef Smolen
Feb 22, 2003·Genes and Immunity·M van der PaardtI E van der Horst-Bruinsma
Apr 16, 2003·Annals of the Rheumatic Diseases·J VencovskýS Růzicková
Aug 19, 2003·Annals of the Rheumatic Diseases·D M Lee, P H Schur
Feb 8, 2005·Annals of the Rheumatic Diseases·B Vander CruyssenF De Keyser
Feb 15, 2005·Annals of the Rheumatic Diseases·P S Helliwell, W J Taylor
Aug 13, 2005·Annals of the Rheumatic Diseases·G M AleniusS Rantapää Dahlqvist
Oct 7, 2005·Arthritis Research & Therapy·Annette H M van der Helm-van MilTom W J Huizinga

❮ Previous
Next ❯

Citations

Apr 21, 2007·Rheumatology International·Rim SghiriIbtissem Ghedira
Jun 18, 2009·Rheumatology International·Abdullah UyanikRamazan Cetinkaya
Dec 20, 2011·Rheumatology·David S GibsonMark W Duncan
Apr 16, 2008·International Journal of Clinical Practice·K CefleA Selek
Aug 14, 2010·International Journal of Rheumatic Diseases·Rafi RajaKamal Solanki
Mar 21, 2009·BMC Research Notes·Nermeen S A Abdel FattahEl Sayed E El Okda
Feb 12, 2014·Rheumatology International·Rodolfo Perez-AlaminoLuis R Espinoza
Jan 14, 2010·Clinical Rheumatology·Andrea Tesija-KunaNada Vrkic
Feb 14, 2008·Clinical Reviews in Allergy & Immunology·Hannah Poulsom, Peter J Charles
May 16, 2009·Rheumatology International·Burcu ÖnderMüfit Akyüz
Dec 22, 2011·Rheumatology International·Kamal EsalatmaneshMohammadreza Nikbakht
Aug 13, 2013·Joint, Bone, Spine : Revue Du Rhumatisme·Gulsen OzenNevsun Inanc
Oct 31, 2009·Arthritis and Rheumatism·Rohit AggarwalKaren H Costenbader
Jan 25, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jun LiaoCangel Pui-yee Chan
Aug 30, 2008·Journal of Dermatological Science·Sayaka ShibataKunihiko Tamaki
Mar 13, 2016·Autoimmunity Reviews·P ConigliaroR Perricone
May 3, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·M K VerheulD J Veale
Oct 18, 2015·Rheumatic Diseases Clinics of North America·Tristan Boyd, Arthur Kavanaugh
Dec 17, 2008·Annals of the New York Academy of Sciences·Walther J van VenrooijGer J M Pruijn
Dec 8, 2011·Arthritis Care & Research·Penélope Esther PalominosLaure Gossec
May 29, 2010·The Journal of Dermatology·Hideki MaejimaKensei Katsuoka
Mar 3, 2010·Immunological Reviews·Ann Duskin, Robert A Eisenberg
Nov 1, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Andrea Tesija Kuna
Oct 21, 2016·Expert Review of Clinical Immunology·Salvatore D'AngeloIgnazio Olivieri
Dec 9, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·P GisondiG Girolomoni
Apr 25, 2019·The Journal of Dermatological Treatment·Alice Gottlieb, Joseph F Merola

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.